OCTANT logo

OCTANT Funding & Investors

Octant, Inc. operates as a biotechnology company. The Company develops a multiplexed technology that uses synthetic biology, genome engineering, next-generation sequencing, and computational tools to measure the activity of receptor pathways in human cells. Octant serves customers in the United States.

https://www.octant.bio/

Total Amount Raised: $115,000,000

OCTANT Funding Rounds

  • Series B

    $80,000,000

    Series B Investors

    Catalio Capital Management
    Fifty Years
    Andreessen Horowitz
    Bristol-Myers Squibb
    Allen & Company
    What If Ventures
    Flucas Ventures
    Bioverge
  • Series A

    $30,000,000

    Series A Investors

    Andreessen Horowitz
    8VC
    SVA
    Allen & Company
    Sujay Jaswa
    Fifty Years
    Ling Wong
  • Seed

    $5,000,000

    Seed Investors

    Lux Capital
    Refactor Capital
    SVA
    Ulu Ventures
    Katie Haun
    Lars Fjeldsoe-Nielsen
    Four Cities Capital
Funding info provided by Diffbot.